Dextera Surgical Inc  

(Public, NASDAQ:DXTR)   Watch this stock  
Find more results for dxtr
0.153
+0.002 (0.99%)
Nov 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.15 - 0.15
52 week 0.11 - 2.33
Open 0.15
Vol / Avg. 0.00/5.85M
Mkt cap 7.35M
P/E     -
Div/yield     -
EPS -1.77
Shares 48.21M
Beta -1.27
Inst. own 5%
Oct 5, 2017
Q1 2018 Dextera Surgical Inc Corporate Sales Call - Webcast
Sep 26, 2017
Dextera Surgical Inc at Ladenburg Thalmann Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin -509.65% -503.24%
Operating margin -551.73% -426.44%
EBITD margin - -409.23%
Return on average assets -184.23% -140.26%
Return on average equity - -
Employees 50 -
CDP Score - -

Address

900 Saginaw Dr
REDWOOD CITY, CA 94063-4753
United States - Map
+1-650-3649975 (Phone)
+1-650-3694024 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

Officers and directors

Julian N Nikolchev President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Robert Y. Newell IV Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Thomas J. Palermo Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Liam J. Burns Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Gregory P. Watson Vice President of operation
Age: 60
Bio & Compensation  - Reuters
Michael A. Bates Director
Age: 57
Bio & Compensation  - Reuters
Gregory D. Casciaro Director
Age: 57
Bio & Compensation  - Reuters
Robert Michael Kleine Director
Age: 63
Bio & Compensation  - Reuters
Samuel E. Navarro Director
Age: 59
Bio & Compensation  - Reuters